Opportunity Information: Apply for PAR 24 164
The Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional), funding opportunity number PAR-24-164, is a National Institutes of Health (NIH) grant led by the National Institute of Mental Health (NIMH), Division of AIDS Research (DAR). It supports the creation or strengthening of HIV/AIDS Research Centers (often referred to as ARCs) through a P30 "Center Core" mechanism. The main purpose is not to fund a single research project, but to build and maintain shared infrastructure, resources, and expertise that make multiple HIV and mental health research projects more productive, higher impact, and better coordinated. In practice, this kind of award is designed to help institutions organize interdisciplinary teams, share specialized tools and services, and accelerate the pace and quality of research that aligns with the NIMH mission at the intersection of HIV/AIDS and mental health.
The NOFO places a strong emphasis on innovative, interdisciplinary science across a wide range of research areas. It explicitly welcomes work spanning basic science, NeuroHIV (the neurological and neuropsychiatric dimensions of HIV), behavioral and social science, integrated biobehavioral research, and more applied lines of inquiry such as clinical, translational, and implementation science. The "clinical trial optional" label means applicants may propose center activities that include clinical trials, but they are not required to do so; the center can be built around infrastructure that supports clinical trials, non-trial clinical research, or preclinical and population-level work, as long as the overall focus is high impact HIV/AIDS and mental health research relevant to NIMH priorities.
Because this is a P30 infrastructure award, the expected deliverable is a well-justified set of "cores" and shared services that enable multiple investigators and projects to succeed. Typical center components in P30 programs often include administrative coordination, shared research support services, methods and statistics support, community and stakeholder engagement capacity, clinical research support, data management, training and mentoring activities, and mechanisms for fostering new collaborations or pilot work. The underlying idea is to reduce duplication, raise scientific rigor and consistency across projects, and create an environment where emerging and established investigators can generate stronger proposals, publish more impactful findings, and move evidence into practice more efficiently.
Eligibility is broad across U.S.-based organizations. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; Native American tribal organizations other than federally recognized governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education in those nonprofit categories); for-profit organizations other than small businesses; and small businesses. The opportunity also calls out several institution types as eligible, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, tribal governments other than federally recognized, and U.S. territories or possessions. At the same time, it clearly restricts foreign involvement: non-domestic (non-U.S.) entities are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as NIH defines them in the NIH Grants Policy Statement) are not allowed.
This is a discretionary grant in the health funding category, listed under CFDA 93.242. The opportunity was created on 2024-03-22, and the original closing date is 2026-08-25. An explicit award ceiling is not provided in the source information you shared, and the expected number of awards is also not specified there, which typically means applicants need to rely on the full NOFO details and NIH budget guidance for the P30 mechanism when developing a realistic budget request and scope.
Overall, PAR-24-164 is aimed at institutions that want to build a durable, shared research infrastructure for HIV/AIDS and mental health science, with the expectation that the center will enable multiple lines of inquiry and multiple investigators to produce stronger, more coordinated, and more impactful research than they could achieve working in isolation.Apply for PAR 24 164
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
- This funding opportunity was created on 2024-03-22.
- Applicants must submit their applications by 2026-08-25. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) - PAR-24-164
What is PAR-24-164?
PAR-24-164 is a National Institutes of Health (NIH) funding opportunity for a Developmental AIDS Research Center on Mental Health and HIV/AIDS using the P30 Center Core grant mechanism. It is led by the National Institute of Mental Health (NIMH), Division of AIDS Research (DAR).
What is the main purpose of this opportunity?
The main purpose is to create or strengthen HIV/AIDS Research Centers (often called ARCs) by building and maintaining shared infrastructure, resources, and expertise that support multiple HIV and mental health research projects. It is designed to make many projects more productive, higher impact, and better coordinated, rather than funding one standalone research project.
Is this grant meant to fund a single research study?
No. This is a P30 infrastructure (Center Core) award. The expected deliverable is a well-justified set of cores and shared services that enable multiple investigators and multiple projects to succeed.
What does "P30 Center Core" mean in practice?
A P30 Center Core award typically supports shared "core" resources and services that many research teams can use. The intent is to reduce duplication across projects, raise scientific rigor and consistency, and build a collaborative environment that accelerates research and increases impact.
What kinds of center components or "cores" are expected?
While specific cores must be justified by the applicant, typical P30 components often include administrative coordination, shared research support services, methods and statistics support, community and stakeholder engagement capacity, clinical research support, data management, training and mentoring activities, and mechanisms for fostering new collaborations or pilot work.
What research areas does the NOFO emphasize?
The NOFO emphasizes innovative, interdisciplinary science across a wide range of areas, including basic science, NeuroHIV (neurological and neuropsychiatric dimensions of HIV), behavioral and social science, integrated biobehavioral research, and applied areas such as clinical, translational, and implementation science.
What does "Clinical Trial Optional" mean?
"Clinical trial optional" means the center may include activities that involve clinical trials, but clinical trials are not required. A center can be built around infrastructure that supports clinical trials, non-trial clinical research, or preclinical and population-level work, as long as the overall focus aligns with NIMH priorities at the intersection of HIV/AIDS and mental health.
Who is the lead NIH institute for this opportunity?
The opportunity is led by the National Institute of Mental Health (NIMH), specifically the Division of AIDS Research (DAR).
What types of organizations are eligible to apply?
Eligibility is broad across U.S.-based organizations. Eligible applicants include various levels of government (state, county, city or township, special district), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, federally recognized Native American tribal governments, Native American tribal organizations other than federally recognized governments, public housing authorities/Indian housing authorities, nonprofits (with or without 501(c)(3) status, within the limits described), for-profit organizations other than small businesses, and small businesses.
Are specific institution types explicitly called out as eligible?
Yes. The opportunity calls out eligibility for Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, tribal governments other than federally recognized, and U.S. territories or possessions.
Can foreign (non-U.S.) organizations apply?
No. Non-domestic (non-U.S.) entities are not eligible to apply.
Can a U.S. organization include a non-U.S. component?
No. Non-domestic components of U.S. organizations are not eligible, and foreign components (as NIH defines them in the NIH Grants Policy Statement) are not allowed.
What is the funding category and assistance listing information?
This is a discretionary grant in the health funding category and is listed under CFDA 93.242.
When was this opportunity created?
The opportunity was created on 2024-03-22.
What is the closing date?
The original closing date provided is 2026-08-25.
Is there an award ceiling listed?
No explicit award ceiling is provided in the information shared.
Is the expected number of awards provided?
No. The expected number of awards is not specified in the information shared.
How should applicants approach budgeting given the missing ceiling information?
Because an explicit award ceiling is not provided here, applicants typically need to rely on the full NOFO details and NIH budget guidance for the P30 mechanism when developing a realistic budget request and an appropriately scoped set of cores and services.
What is the overall goal of establishing or strengthening an HIV/AIDS Research Center under this program?
The overall goal is to build durable, shared research infrastructure for HIV/AIDS and mental health science so that multiple investigators and lines of inquiry can produce stronger, more coordinated, and more impactful research than they could achieve working in isolation.
Browse more opportunities from the same category: Health
Next opportunity: Administrative Support – American Spaces in Sri Lanka
Previous opportunity: Ambassador’s Special Self-Help Program, POL/ECON, U.S. Embassy Yaounde
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 24 164
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 24 164) also looked into and applied for these:
| Funding Opportunity |
|---|
| Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed) Apply for RFA RM 24 007 Funding Number: RFA RM 24 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Centers for Research in Emerging Infectious Diseases (CREID) Network Coordination Center (U01 Clinical Trial Not Allowed) Apply for RFA AI 24 016 Funding Number: RFA AI 24 016 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed) Apply for RFA AI 24 006 Funding Number: RFA AI 24 006 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| NINDS Program Project Grant (P01 Clinical Trial Optional) Apply for PAR 24 169 Funding Number: PAR 24 169 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowed) Apply for RFA AI 24 008 Funding Number: RFA AI 24 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical Trial Not Allowed) Apply for RFA AI 24 010 Funding Number: RFA AI 24 010 Agency: National Institutes of Health Category: Health Funding Amount: $3,500,000 |
| Limited Competition: Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional) Apply for RFA HL 26 001 Funding Number: RFA HL 26 001 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Limited Interaction Targeted Epidemiology: Epidemiology of Transmission and Treatment of HIV Among People Who Are at Increased Risk for HIV Infection in Latin America (LITE-LA) (UG3/UH3 Clinical Trial Optional) Apply for RFA AI 24 009 Funding Number: RFA AI 24 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging findings in ARIA (U24 - Clinical Trials Not Allowed) Apply for RFA NS 24 034 Funding Number: RFA NS 24 034 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Maximizing Access to Research Careers (MARC) (T34) Apply for PAR 24 138 Funding Number: PAR 24 138 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34) Apply for PAR 24 137 Funding Number: PAR 24 137 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| GH Social and Behavior Change (SBC) Activity Apply for 7200AA24RFA00008 Funding Number: 7200AA24RFA00008 Agency: Agency for International Development Category: Health Funding Amount: $321,500,000 |
| Research to Advance the Science of Primary Care (R01) Apply for PA 24 205 Funding Number: PA 24 205 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed) Apply for RFA AI 24 019 Funding Number: RFA AI 24 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria (R01 Clinical Trial Not Allowed) Apply for RFA AI 24 021 Funding Number: RFA AI 24 021 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed) Apply for RFA AI 24 020 Funding Number: RFA AI 24 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) Apply for PAR 24 172 Funding Number: PAR 24 172 Agency: National Institutes of Health Category: Health Funding Amount: $1,515,000 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required) Apply for PAR 24 173 Funding Number: PAR 24 173 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| USAID Kenya and East Africa (KEA) Social and Behavior Change (SBC) Activity Apply for 72061524RFA00004 Funding Number: 72061524RFA00004 Agency: Kenya USAID-Nairobi Category: Health Funding Amount: $14,950,000 |
| Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) Apply for RFA TR 24 023 Funding Number: RFA TR 24 023 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 24 164", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
